MIMETAS
PrivateLast Round
Grant
Jul 7, 2024
Total Funding Raised
$32.96M
Company Overview
MIMETAS is a biotechnology company that develops and markets organ-on-a-chip products and 3D tissue models for drug development, compound testing, and research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MIMETAS Comparables
Compare MIMETAS with similar companies based on industry and business-model similarity.
MIMETAS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 7, 2024 | ||||
| Grant | Feb 22, 2022 | ||||
| Series B | Apr 11, 2018 | ||||
| Grant | Dec 22, 2015 | ||||
| Series A | Oct 8, 2014 | ||||
Grant | Sep 11, 2014 |
Key People
Founding team and executive leadership
MIMETAS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission (Horizon Europe) | Grant |
| Zeeuws InvesteringsFonds | Series A |
| NC3Rs | Grant |
| Korys | Series B |
| European Life Sciences Growth Fund | Series B |
| Institute for Risk Assessment Sciences | Grant |
| Cathay Venture | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2025
Attended SLAS 2025 and launched new OrganoPlate UniFlow technology.
- Jan 27, 2025
OrganoPlate UniFlow technology unveiled at SLAS 2025.
Recent news
Latest coverage and updates
- is_developingSep 20, 2026
Mimetas B.V is developing integrated product and service workflows.
- is_developingAug 10, 2026
MIMETAS - The Organ on a Chip Company is developing scalable organ-on-a-chip platforms and human tissue models on Aug 10th '26.
MIMETAS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MIMETAS's valuation, stock price, and market status.
Is MIMETAS a public or private company?
MIMETAS is a private company.
What is the current stock price of MIMETAS?
MIMETAS is a private company with no public stock price. No recent secondary market data is available.
How much is MIMETAS worth (valuation)?
Valuation information for MIMETAS is not publicly available.
Can I buy MIMETAS stock?
MIMETAS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MIMETAS's last funding round?
MIMETAS's most recent funding round was Grant on July 7, 2024.
Who are the main investors in MIMETAS?
Key investors in MIMETAS include European Commission (Horizon Europe), NC3Rs.
Will MIMETAS IPO soon?
No public IPO plans have been announced for MIMETAS.
How can I track MIMETAS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MIMETAS's secondary market activity and sign up for updates.